What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His scientific interests lie mostly in Rheumatoid arthritis, Internal medicine, Surgery, Arthritis and Rheumatology.
His Rheumatoid arthritis research integrates issues from Connective tissue disease, Physical therapy, Methotrexate and Rituximab.
His biological study spans a wide range of topics, including Gastroenterology and Placebo.
As a member of one scientific family, he mostly works in the field of Gastroenterology, focusing on Infliximab and, on occasion, Etanercept.
His work investigates the relationship between Arthritis and topics such as Pathology that intersect with problems in Synovial membrane.
His Rheumatology study combines topics in areas such as Rheumatoid factor, Visual analogue scale, Rheumatism, Pharmacotherapy and Abatacept.
His most cited work include:
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. (4441 citations)
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update (3425 citations)
- Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. (2688 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Rheumatoid arthritis, Immunology, Arthritis and Rheumatology.
His research integrates issues of Gastroenterology, Placebo and Surgery in his study of Internal medicine.
He combines subjects such as Severity of illness, Adverse effect and Infliximab with his study of Surgery.
His study in the field of Synovitis is also linked to topics like In patient.
His research on Arthritis often connects related areas such as Pathology.
His Rheumatology research incorporates themes from Rheumatism and Cohort.
He most often published in these fields:
- Internal medicine (66.85%)
- Rheumatoid arthritis (60.74%)
- Immunology (24.62%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (66.85%)
- Rheumatoid arthritis (60.74%)
- Arthritis (22.27%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Rheumatoid arthritis, Arthritis, Clinical trial and Synovitis.
His research on Internal medicine often connects related topics like Gastroenterology.
His study in Rheumatoid arthritis is interdisciplinary in nature, drawing from both Methotrexate, Discontinuation and Oncology.
He has included themes like Placebo and Early rheumatoid arthritis in his Methotrexate study.
The various areas that he examines in his Arthritis study include Randomized controlled trial and Autoimmunity, Disease.
Paul Emery focuses mostly in the field of Synovitis, narrowing it down to matters related to Inflammatory arthritis and, in some cases, Odds ratio.
Between 2017 and 2021, his most popular works were:
- Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia (292 citations)
- Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia (292 citations)
- Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force (260 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
His scientific interests lie mostly in Internal medicine, Rheumatoid arthritis, Arthritis, Clinical trial and Rheumatology.
His research in Internal medicine intersects with topics in Gastroenterology and Placebo.
His Rheumatoid arthritis research incorporates elements of Discontinuation, Cohort and Rituximab.
His Arthritis research includes themes of Magnetic resonance imaging, Lupus erythematosus and Autoimmunity.
His work carried out in the field of Clinical trial brings together such families of science as Psoriatic arthritis, Systematic review, Adverse effect, Evidence-based medicine and Methylprednisolone acetate.
His Rheumatology research includes elements of Rheumatism, Severity of illness and Abatacept.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
